In DTCs obtained by treating EGFR-mutated non-small cell lung cancer cells (NSCLC) with gefitinib, a significant upregulation of the mTOR-mediated anti-apoptotic protein MCL1 could be found, indicating that DTCs are closely associated with anti-apoptosis (24). This evidence concerns the gene MTOR and non-small cell lung carcinoma.